You are here:

MS in the media - 15 October 2015

Published on

These are links to recent news stories that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

ECTRIMS reports

General reports from ECTRIMS, a the recent major European conference on MS research, include ocrelizumab, Biotin, Anti-LINGO-1, Lemtrada, genes, teriflunomide and minocycline

Source: MS Research Australia
Source: Canadian MS Society blog
Source: MS International Federation

MS Trust link: Drugs in development

Aubagio and brain tissue loss

A reanalysis of data on teriflunomide (Aubagio) presented at the ECTRIMS conference showed the drug slowed the build up of brain atrophy

Source: MedPage Today

MS Trust link: Teriflunomide (Aubagio)

Generic version of glatiramer acetate is effective

A generic version of glatiramer acetate showed similar effect on the number of new lesions shown by MRI and had similar side effects to Copaxone, the branded version of the drug used to treat relapsing MS.

Source: MedPage Today 

MS Trust link: Glatiramer acetate (Copaxone)